Ion-transporting activity in the murine colonic epithelium of normal animals and animals with cystic fibrosis.
Electrogenic ion transport in the isolated colonic epithelium from normal and transgenic mice with cystic fibrosis (CF mice) has been investigated under short-circuit current (Isc) conditions. Normal tissues showed chloride secretion in response to carbachol or forskolin, which was sensitive to the Na-K-2Cl cotransport inhibitor, frusemide. Responses to both agents were maintained for at least 12 h in vitro, but the responses to carbachol changed in format throughout this period. By contrast CF colons failed to show the normal secretory responses to carbachol and forskolin, most preparations showing a decrease in Isc that was immediately reversed by frusemide. In CF colons addition of Ba2+ ions or tetraethylammonium (TEA+) to the apical bathing solution antagonised the reduction in Isc caused by the secretagogues. It is concluded that the reduction in Isc in CF colons is due to electrogenic K+ secretion and this was confirmed by flux studies using rubidium-86. In normal colons exposed to TEA+ the responses to forskolin were greater, but not significantly so, presumably because the minor K(+)-secretory responses are dominated by major chloride-secretory responses. Again rubidium-86 fluxes showed an increase of K+ secretion in normal colons receiving forskolin. Since the amiloride-sensitive current was not different in CF and normal colons there was no evidence that the CF mice were stressed in a way that increased mineralocorticoid levels and hence K+ secretion. Knowledge of the phenotype of the colonic epithelium of the CF mouse sets the baseline from which attempts at gene therapy for the gut must be judged.
Cuthbert
A W
AW
Department of Pharmacology, University of Cambridge, UK.
MacVinish
L J
LJ
Hickman
M E
ME
Ratcliff
R
R
Colledge
W H
WH
Evans
M J
MJ
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D003106:Colon / Q000378:metabolism*; D003550:Cystic Fibrosis / Q000378:metabolism*; D004848:Epithelium; D005665:Furosemide / Q000494:pharmacology; D007477:Ions; D051379:Mice; D018181:Mice, Inbred CFTR; D011188:Potassium / Q000378:metabolism*; D012414:Rubidium Radioisotopes / Q000378:metabolism; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000378:metabolism
D007477:Ions; D012414:Rubidium Radioisotopes; D013757:Tetraethylammonium Compounds; D005576:Colforsin; D019789:Tetraethylammonium; D000584:Amiloride; D005665:Furosemide; D002217:Carbachol; D011188:Potassium